PP
Propanc Biopharma, Inc.
PPCB · NASDAQ
$0.61 -7.99% (-$0.05)
1M -47.41%
Market Cap $1.44M
P/E Ratio -
Div. Yield -
ROE 148.23%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.15x
P/FCF N/A
P/FFO N/A
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
0 /100
Poor Asset turnover 0.00x
ROA 128.10%
ROIC 161.15%
Debt
69 /100
Low Current ratio 2.37x
Int. coverage -26.93x
Debt/Equity 0.16x
Stability
44 /100
Moderate EPS volatility 1.31%
Profitable years 0
Beta 3.33x
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na PPCB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
James Nathanielsz
Employees
2
Headquarters
Camberwell